Apricus Biosciences, Inc. (APRI) Tops Q2 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. VZ

Go back to Apricus Biosciences, Inc. (APRI) Tops Q2 EPS by 9c

Apricus Biosciences Provides Corporate Update and Second Quarter 2014 Financial Results

August 12, 2014 7:00 AM EDT

Vitaros® Launch in Europe Exceeds Company's Expectations

Established a $22 Million Equity Facility with Existing Long-Term Shareholder

Conference Call and Webcast Today, Tuesday, August 12, 2014 at 8:00 a.m. ET

SAN DIEGO, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today provided a corporate update and reported financial results for the second quarter 2014.

"We are pleased with the substantial progress... More